Hero Image

Building the Future of Objective Dry Eye Screening



ThermOcular is developing AI-powered imaging technology to measure tear film dynamics — enabling rapid, objective dry eye screening in routine clinical exams.

Patented in the U.S. and Canada. Developed at the University of Waterloo.

Hero Image
Building the Future of Objective Dry Eye Screening


ThermOcular is developing AI-powered imaging technology to measure tear film dynamics — enabling rapid, objective dry eye screening in routine clinical exams.

Patented in the U.S. and Canada. Developed at the University of Waterloo.

Hero Image

Building the Future of Objective Dry Eye Screening



ThermOcular is developing AI-powered imaging technology to measure tear film dynamics — enabling rapid, objective dry eye screening in routine clinical exams.

Patented in the U.S. and Canada. Developed at the University of Waterloo.

Clinical Traction & Progress

78 patients clinically tested

— Validation in controlled clinical environment

— Reproducible measurements across subjects

— Sensitive to tear film dynamics

Early clinical adoption underway

— 8 Letters of Intent (LOIs) signed with clinics

— Additional partnerships in progress

— Targeting expanded clinical adoption by 2027

Early clinical adoption underway

— 8 Letters of Intent (LOIs) signed with clinics

— Additional partnerships in progress

— Targeting expanded clinical adoption by 2027

Ongoing clinical studies

— Diagnostic performance in dry eye populations

— Tearfilm volume measurements and metrics

— Tear film stability / break-up

Ongoing clinical studies

— Diagnostic performance in dry eye populations

— Tearfilm volume measurements and metrics

— Tear film stability / break-up

From Imaging to Clinical Insight

ThermOcular transforms synchronized thermal and visible imaging into a quantitative measure of eye surface behavior — enabling objective assessment of tear film stability in real time.

Why ThermOcular Exists

Dry Eye Is Common — But Underdiagnosed

— Up to 30–50% of patients may be affected

— Symptoms are subjective and inconsistent

— Testing is slow and performed outside routine exams

— Many patients remain undiagnosed

Dry Eye Is Common — But Underdiagnosed

— Up to 30–50% of patients may be affected

— Symptoms are subjective and inconsistent

— Testing is slow and performed outside routine exams

— Many patients remain undiagnosed

A New Approach to Screening

— Objective measurement in 30 seconds

— Quantifies tear film behavior in real time

— Enables same-visit clinical decisions

— Non-contact and workflow-friendly

A New Approach to Screening

— Objective measurement in 30 seconds

— Quantifies tear film behavior in real time

— Enables same-visit clinical decisions

— Non-contact and workflow-friendly

Our Vision

To make objective ocular surface measurement a standard part of every eye exam.
Objective Measurement

— Quantifies eye surface cooling

— Removes subjective assessment

— Ensures consistent, repeatable results

Objective Measurement

— Quantifies eye surface cooling

— Removes subjective assessment

— Ensures consistent, repeatable results

Objective Measurement

— Quantifies eye surface cooling

— Removes subjective assessment

— Ensures consistent, repeatable results

Fast & Practical

— 30-second screening workflow

— Designed for routine eye exams

— No disruption to clinic operations

Fast & Practical

— 30-second screening workflow

— Designed for routine eye exams

— No disruption to clinic operations

Clinically Actionable

— Supports earlier detection of dry eye

— Improves clinical decision-making

— Enables better patient outcomes

Clinically Actionable

— Supports earlier detection of dry eye

— Improves clinical decision-making

— Enables better patient outcomes

Built by Experts in Vision Science, Clinical Research, and AI

Team Image
Team Image
Ehsan Zare Bidaki
CEO & Co-Founder

PhD, University of Waterloo

— PhD in Vision Science & Systems Design Engineering

— AI and System design expert

Team Image
Team Image
Paul J. Murphy
CSO & Co-Founder

PhD, Glasgow Caledonian University

— Professor, School of Optometry & Vision Science

— Leading researcher in tear film and dry eye

Team Image
Team Image
Team Image
Parvaneh Najafizadeh
Clinical Scientist

PhD, Shiraz University

— Research Assistant at University of Waterloo

— Clinical validation & Data Analyst

News & Updates

Latest progress in clinical validation, research, and adoption.
Image
Conference Presentation — March 2026
Presented at NCC 2026
ThermOcular was presented at the BCLA Scientific Stream during NCC 2026, highlighting ocular surface cooling as an objective biomarker for dry eye.
Clinical Validation — April 2026
Manuscript Submitted (CLAE)
A clinical validation study of ThermOcular in healthy eyes has been submitted to Contact Lens & Anterior Eye and is currently under peer review.
Image
Image
Clinical Progress — Ongoing
Ongoing Clinical Study
ThermOcular is being evaluated in a clinical study to assess diagnostic performance in dry eye populations.
Jun 2024
University of Waterloo Highlights ThermOcular
Featured by Waterloo News for advancing non-contact thermal imaging technology for rapid ocular surface assessment.
Reade more…

Image

Work With Us

Join us in bringing objective dry eye screening into routine clinical care.

Contact / Partner

Contact / Partner